MedPath

Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization

Not Applicable
Conditions
CARDIAC CATHETRIZATION
Interventions
Device: radial artery compression device
Device: ulnar artery compression device
Device: radial artery compression device guided with plysthmography
Registration Number
NCT03182530
Lead Sponsor
Assiut University
Brief Summary

Data from literature: transradial access failure sometimes occurs due to inability to cannulate the radial artery due to radial artery spasm1 causing severe difficulties in manipulation of the guide wires and catheters along the tortuous pathways of the arteries. both mechanical stimuli and circulating catecholamines through activation of α1-adrenoreceptors, causing smooth muscle cell contraction \& radial artery spasm

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Normal radial artery and of size ≥ 2mm by duplex.
  • Normal ulnar artery by duplex.
Read More
Exclusion Criteria
  • Pre-procedural duplex detection of radial artery anomalies as hypoplasia, tortousity, severe calcification or radial artery diameter < 2 mm.
  • Severe renal failure (creatinine clearance < 30 ml/min).
  • Known peripheral vascular disease.
  • Emergency procedures.
  • Failure to successfully cannulate the radial artery was also a criterion for exclusion.
  • Patients on warfarin therapy.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
control groupradial artery compression device-
ULTRA method groupulnar artery compression device-
ULTRA method groupradial artery compression device-
standard patent hemostasis groupradial artery compression device guided with plysthmography-
Primary Outcome Measures
NameTimeMethod
The percentage of occurrence of radial artery occlusion1 hour

the assessment will be done after compression device removal guided by duplex post trans-radial cardiac catheterization.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath